Maintaining the balance between benefits and risks: The example of hyperkalemia in patients with heart failure

Maintaining the balance between benefits and risks: The example of hyperkalemia in patients with heart failure

Show other versions (1)

Bibliographic Details
Main Author:	Aldo P. Maggioni
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Revista Portuguesa de Cardiologia (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2174204920303202

Similar Items

Maintaining the balance between benefits and risks: The example of hyperkalemia in patients with heart failure
by: Aldo P. Maggioni
Published: (2020-09-01)

Hyperkalemia in heart failure patients: current challenges and future prospects
by: López-Vilella R, et al.
Published: (2016-02-01)

Hematochezia in a Patient with Renal Failure and Hyperkalemia
by: Tânia Meira, et al.
Published: (2015-05-01)

Debate: Should statin be used in patients with heart failure?
by: Pietro Maggioni Aldo
Published: (2001-11-01)

Hyperkalemia-induced complete heart block
by: Alireza Baratloo, et al.
Published: (2015-05-01)

Characteristics, Risk Factors, and Adverse Outcomes of Hyperkalemia in Acute-on-Chronic Liver Failure Patients
by: Jun-jun Cai, et al.
Published: (2019-01-01)

Uncovering difference: a glimpse at patients with heart failure in low-income and middle-income countries
by: Aldo P Maggioni
Published: (2017-07-01)

Chronic renal failure, hyperkalemia, and colonic ulcers
by: S A George, et al.
Published: (2014-01-01)

High blood tacrolimus and hyperkalemia in a heart transplant patient
by: Manoj Kumar Sahu, et al.
Published: (2017-01-01)

Use of Valsartan in Post-Myocardial Infarction and Heart Failure Patients
by: Peter P Liu, et al.
Published: (2006-03-01)

Use of Valsartan in Post-Myocardial Infarction and Heart Failure Patients
by: Peter P Liu, et al.
Published: (2006-03-01)

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
by: Giuseppe MC Rosano, et al.
Published: (2019-11-01)

Hyperkalemia and rhabdomyolyssis
by: Sora Yasri, et al.
Published: (2015-01-01)

Hyperkalemia on ECG
by: Bryson Hicks
Published: (2016-09-01)

Electrocardiographic manifestations of hyperkalemia in hemodialysis patients
by: Nemati Eghlim, et al.
Published: (2010-01-01)

Management of hyperkalemia in the acutely ill patient
by: François Dépret, et al.
Published: (2019-02-01)

SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
by: R. Eschalier, et al.
Published: (2015-09-01)

SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
by: R. Eschalier, et al.
Published: (2015-09-01)

Risk factors of hyperkalemia after total parathyroidectomy in patients with secondary hyperparathyroidism
by: Yun Zou, et al.
Published: (2020-01-01)

Hyperkalemia and severe rhabdomyolysis
by: Marc Mugmon
Published: (2011-10-01)

An unseen ′face′ of hyperkalemia
by: Dilip Gude, et al.
Published: (2013-01-01)

Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
by: Urbanek I, et al.
Published: (2014-04-01)

Nicorandil-Induced Hyperkalemia in a Uremic Patient
by: Hung-Hao Lee, et al.
Published: (2012-01-01)

Hyperkalemia and management of renin-angiotensin-aldosterone system inhibitors in chronic heart failure with reduced ejection fraction: A systematic review
by: Cândida Fonseca, et al.
Published: (2020-09-01)

Hyperkalemia and management of renin-angiotensin-aldosterone system inhibitors in chronic heart failure with reduced ejection fraction: A systematic review
by: Cândida Fonseca, et al.
Published: (2020-09-01)

The Benefits of Yoga Therapy for Heart Failure Patients
by: Pullen, Paula Rei
Published: (2009)

Ranolazine Induced Bradycardia, Renal Failure, and Hyperkalemia: A BRASH Syndrome Variant
by: Syed Arsalan Akhter Zaidi, et al.
Published: (2019-01-01)

Hiperpotassemia na vigência de espironolactona em pacientes com insuficiência cardíaca descompensada Hyperkalemia during spironolactone use in patients with decompensated heart failure
by: Marcelo Villaça Lima, et al.
Published: (2008-09-01)

Patient, hospital and country-level risk factors of all-cause mortality among patients with chronic heart failure: Prospective international cohort study.
by: Benedetta Pongiglione, et al.
Published: (2021-01-01)

Cardiac Arrest with Extreme Hyperkalemia
by: Yasuharu Tokuda
Published: (2017-12-01)

Hyperkalemia and chronic kidney disease
by: S.V. Kushnirenko
Published: (2019-02-01)

Hyperkalemia - a review article
by: Marcin Makuch, et al.
Published: (2019-07-01)

Electrocardiogram Sine Wave in Hyperkalemia
by: Cornelius, Brian G, et al.
Published: (2010-02-01)

Treatment and pathogenesis of acute hyperkalemia
by: Yelena Mushiyakh, et al.
Published: (2012-01-01)

Rhabdomyolysis-Induced Severe Hyperkalemia
by: Rosenberry, Clark, et al.
Published: (2009-11-01)

The Cost of Hyperkalemia in the United States
by: Keith A. Betts, et al.
Published: (2018-03-01)

Hyperkalemia induced Brugada phenocopy
by: Janaki Rami Reddy Manne, et al.
Published: (2021-02-01)

The burden of hyperkalemia in Germany – a real world evidence study assessing the treatment and costs of hyperkalemia
by: Jennifer Scarlet Haas, et al.
Published: (2020-08-01)

The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia
by: Ljiljana Crnobrnja, et al.
Published: (2020-12-01)

Acute hyperkalemia induced by hyperglycemia in non-diabetic patient
by: Sun Young Park, et al.
Published: (2011-08-01)